ANALISIS EFEKTIVITAS BIAYA PADA PASIEN INFEKSI SALURAN KEMIH (ISK) RAWAT INAP DI RUMAH SAKIT BHAYANGKARA MANADO
DOI:
https://doi.org/10.35799/pha.8.2019.29258Abstract
ABSTRACT
Â
Urinary tract infections are a clinical condition due to the presence of microorganisms in the urine and the potential for invasion of the upper urinary tract, invading the renal pelvic mucosa and extending into the interstitial tissues of the kidneys. Urinary tract infections treated with antibiotics are one of the significant cost categories in the pharmaceutical budget in hospitals. The purpose of this study was to determine a more cost effective therapy between the use of Ceftriaxone and Ciprofloxacin in UTI patients hospitalized at Bhayangkara Hospital, Manado. This study uses a descriptive research method with retrospective data collection. The sample in this study were 36 patients including 15 patients using Ceftriaxone and 21 patients using Ciprofloxacin. The results showed that the most cost-effective antibiotic was Ceftriaxone with an ACER value of IDR 781,890 and ICER value of IDR 551,255.
Â
Keywords: Cost Effectiveness Analysis, Urinary Tract Infections, Ceftriaxone, Ciprofloxacin.
Â
ABSTRAK
Â
Infeksi saluran kemih adalah keadaan klinis akibat adanya mikroorganisme dalam urin dan berpotensi untuk invasi ke saluran kemih bagian atas, menginvasi mukosa pelvis ginjal dan meluas ke dalam jaringan interstisial ginjal. Infeksi saluran kemih diobati dengan antibiotik yang menjadi salah satu kategori biaya yang signifikan dalam anggaran farmasi di rumah sakit. Tujuan penelitian ini untuk menentukan terapi yang lebih cost effective antara penggunaan Seftriakson dan Siprofloksasin pada pasien ISK rawat inap di RS Bhayangkara Manado. Penelitian ini menggunakan metode penelitian deskriptif dengan pengambilan data secara retrospektif. Sampel pada penelitian ini sebanyak 36 pasien diantaranya
15 pasien menggunakan Seftriakson dan 21 pasien menggunakan Siprofloksasin. Hasil penelitian menunjukan, antibiotik yang paling cost-effective adalah Seftriakson dengan nilai ACER sebesar Rp. 781.890 dan nilai ICER sebesar Rp. 551.255.
Â
Kata Kunci : Analisis Efektivitas Biaya, Infeksi Saluran Kemih, Seftriakson, SiprofloksasinDownloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)